Member

Radiatric Inc.

Radiatric Inc. is dedicated to developing and commercializing innovative technologies to improve outcomes for patients with blood stream infections that can lead to sepsis, and septic shock. Antimicrobial resistance is a serious global health threat. Our flagship medical device, our RAD-01 system, is an extracorporeal non-antibiotic device designed to treat blood stream infections by targeting and killing pathogens even multi drug-resistant organisms. The company's focus is on non-pharmacological methods of killing pathogens, aiming to reduce the mortality and long-term effects associated with sepsis.

Industries

N/A

Nr. of Employees

small (1-50)

Radiatric Inc.

https://radiatric.com/

rtribble@radiatric.com

Radiatric Inc. is currently seeking investment

Radiatric Inc. is seeking a seed investment in the range of 1m-5m

All Investment-seeking Members

Products

Extracorporeal light-based blood treatment system

Investigational extracorporeal device that circulates patient blood through a light exposure module using visible and near-UV wavelengths to inactivate bacteria in blood without exogenous photosensitizers; designed for use as an adjunct to dialysis or hemoperfusion and with antibiotics.